{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T12:44:48Z","timestamp":1793623488039,"version":"4.5.0"},"reference-count":35,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"unspecified","delay-in-days":210,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021708","name":"New South Wales Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011025","name":"Government of Western Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003921","name":"Department of Health and Aged Care, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022940","name":"Northern Territory Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022940","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[2025]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:p>Hepatitis B virus vaccination is currently recommended in Australia for adults at an increased risk of acquiring infection or at high risk of complications from infection. This retrospective cohort study used data from an Australian sentinel surveillance system to assess the proportion of individuals who had a recorded test that indicated being susceptible to hepatitis B infection in six priority populations, as well as the proportion who were then subsequently vaccinated within six months of being identified as susceptible. Priority populations included in this analysis were people born overseas in a hepatitis B endemic country, people living with HIV, people with a recent hepatitis C infection, gay, bisexual and other men who have sex with men, people who have ever injected drugs, and sex workers. Results of the study found that in the overall cohort of 43,335 individuals, 14,140 (33%) were identified as susceptible to hepatitis B, and 5,255 (37%) were subsequently vaccinated. Between 26% and 33% of individuals from priority populations were identified as susceptible to hepatitis B infection, and the proportion of these subsequently vaccinated within six months was between 28% and 42% across the groups. These findings suggest further efforts are needed to increase the identification and subsequent vaccination of susceptible individuals among priority populations recommended for hepatitis B vaccination, including among people who are already engaged in hepatitis B care.<\/jats:p>","DOI":"10.1017\/s0950268825100241","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T08:09:03Z","timestamp":1753862943000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":2,"title":["Hepatitis B susceptibility and subsequent vaccination in priority populations across an Australian sentinel surveillance network, 2017<i>\u2013<\/i>2023"],"prefix":"10.1017","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7900-3612","authenticated-orcid":false,"given":"Leila","family":"Bell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Pilcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elly","family":"Layton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Polkinghorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Asselin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4475-5224","authenticated-orcid":false,"given":"Anna","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mish","family":"Pony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Pendle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne","family":"Dimech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Stoov\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret E","family":"Hellard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"S0950268825100241_r20","doi-asserted-by":"publisher","DOI":"10.1111\/1753-6405.12032"},{"key":"S0950268825100241_r11","doi-asserted-by":"publisher","DOI":"10.1071\/SH16002"},{"key":"S0950268825100241_r10","doi-asserted-by":"publisher","DOI":"10.1111\/1753-6405.12316"},{"key":"S0950268825100241_r13","unstructured":"[13] CDA Foundation. Polaris Observatory Countries\/Territories \u2014 Dashboard. https:\/\/cdafound.org\/polaris-countries-dashboard\/#footnote-hbv (accessed 14 June 2024)"},{"key":"S0950268825100241_r6","unstructured":"[6] NSW Government (2022) Hepatitis B Vaccination of Babies. https:\/\/www.healthstats.nsw.gov.au\/indicator?name=-mab-bubs-immun-hepb-pdc&location=NSW&view=Trend&measure=Percent&groups=Hepatitis B birth dose given&compare=Hepatitis B birth dose given&filter=Hepatitis B birth dose given,Dose given (accessed 9 May 2024)."},{"key":"S0950268825100241_r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008"},{"key":"S0950268825100241_r21","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-025-04632-y"},{"key":"S0950268825100241_r5","unstructured":"[5] King, J , McManus, H , Kwon, A , et al. (2022) HIV, Viral Hepatitis and Sexually Transmissible Infections in Australia: Annual Surveillance Report 2022. Sydney, Australia. https:\/\/www.kirby.unsw.edu.au\/sites\/default\/files\/documents\/Annual-Surveillance-Report-2022_HBV.pdf"},{"key":"S0950268825100241_r26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30899"},{"key":"S0950268825100241_r29","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines8010034"},{"key":"S0950268825100241_r12","first-page":"e11028","article-title":"Monitoring the control of sexually transmissible infections and blood-borne viruses: Protocol for the Australian collaboration for coordinated enhanced sentinel surveillance (ACCESS)","volume":"7","author":"Callander","year":"2018","journal-title":"Journal of Medical Internet Research Protocols"},{"key":"S0950268825100241_r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvacx.2022.100225"},{"key":"S0950268825100241_r28","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51114"},{"key":"S0950268825100241_r7","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1016\/j.vaccine.2023.01.045","article-title":"Uptake of perinatal immunoprophylaxis for infants born to women with a record of Hepatitis B in Victoria (2009\u20132017)","volume":"41","author":"HMA","year":"2023","journal-title":"Vaccine"},{"key":"S0950268825100241_r32","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2015.09.011"},{"key":"S0950268825100241_r33","doi-asserted-by":"publisher","DOI":"10.1007\/s11904-019-00461-6"},{"key":"S0950268825100241_r14","unstructured":"[14] World Health Organization (2022) The Global Health Observatory. https:\/\/www.who.int\/data\/gho\/data\/indicators\/indicators-index (accessed 7 October 2023)"},{"key":"S0950268825100241_r19","doi-asserted-by":"publisher","DOI":"10.1007\/s10389-023-01986-2"},{"key":"S0950268825100241_r4","unstructured":"[4] Department of Health and Aged Care (2023) Fourth National Hepatitis B Strategy 2023\u20132030. https:\/\/www.health.gov.au\/sites\/default\/files\/2023-05\/fourth-national-hepatitis-b-strategy-2023-2030.pdf (accessed 9 May 2024)"},{"key":"S0950268825100241_r24","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofz521"},{"key":"S0950268825100241_r23","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac088"},{"key":"S0950268825100241_r27","volume-title":"Global Health Sector Strategies on, Respectively, HIV, Viral Hepatitis and Sexually Transmitted Infections for the Period 2022\u20132030","year":"2022"},{"key":"S0950268825100241_r17","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-019-3926-2"},{"key":"S0950268825100241_r18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31991"},{"key":"S0950268825100241_r30","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7113a1"},{"key":"S0950268825100241_r34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253589"},{"key":"S0950268825100241_r31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207037"},{"key":"S0950268825100241_r9","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51430"},{"key":"S0950268825100241_r1","unstructured":"[1] Australian Technical Advisory Group on Immunisation (ATAGI). Hepatitis B. https:\/\/immunisationhandbook.health.gov.au\/contents\/vaccine-preventable-diseases\/hepatitis-b (accessed 9 May 2024)"},{"key":"S0950268825100241_r3","volume-title":"Guidelines for the Prevention, Care and Treatment of Persons with Chronic Hepatitis B Infection","year":"2024"},{"key":"S0950268825100241_r2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22881"},{"key":"S0950268825100241_r15","doi-asserted-by":"publisher","DOI":"10.1017\/S095026881700098X"},{"key":"S0950268825100241_r22","unstructured":"[22] Victorian Department of Health (2018 ) Immunisation High Risk Groups. https:\/\/www.health.vic.gov.au\/your-health-report-of-the-chief-health-officer-victoria-2018\/immunisation\/immunisation-high-risk (accessed 29 March 2025)"},{"key":"S0950268825100241_r35","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-022-00677-0"},{"key":"S0950268825100241_r8","volume-title":") Australian Immunisation Handbook","year":"2022"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268825100241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T08:09:10Z","timestamp":1753862950000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268825100241\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":35,"alternative-id":["S0950268825100241"],"URL":"https:\/\/doi.org\/10.1017\/s0950268825100241","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"value":"0950-2688","type":"print"},{"value":"1469-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"\u00a9 The Author(s), 2025. Published by Cambridge University Press","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}],"article-number":"e84"}}